BRIEF published on 05/13/2024 at 07:35, 2 years ago S&P Confirms Covivio’s BBB+ Rating with Stable Outlook Real Estate Covivio Financial Stability S&P Rating BBB+ Rating
BRIEF published on 05/13/2024 at 07:23, 2 years ago All for One Group SE Reports Growth and Confirms Fiscal Year Guidance Financial Results Market Growth Dividend Approval Cloud Business SAP Solutions
BRIEF published on 05/13/2024 at 07:23, 2 years ago All for One Group SE annonce une croissance et confirme ses prévisions pour l'exercice financier Résultats Financiers La Croissance Du Marché Solutions SAP Entreprise En Nuage Approbation Du Dividende
BRIEF published on 05/13/2024 at 07:20, 2 years ago Eurofins EAG Laboratories Expands Battery Testing Capabilities Quality Improvement Battery Testing Eurofins Expansion Material Testing Innovation Acceleration
BRIEF published on 05/13/2024 at 07:20, 2 years ago Les laboratoires Eurofins EAG étendent leurs capacités de test de batteries Test De Batterie Amelioration De La Qualite Expansion D'Eurofins Tests De Matériaux Accélération De L'innovation
BRIEF published on 05/13/2024 at 07:05, 2 years ago SIG Combibloc Group AG Announces Successful €450 Million Schuldschein Placement Financial Markets Investor Demand SIG Combibloc Group AG Debt Refinancing Schuldschein
BRIEF published on 05/13/2024 at 07:05, 2 years ago SIG Combibloc Group AG annonce un placement réussi de Schuldschein de 450 millions d'euros Marchés Financiers Demande Des Investisseurs SIG Combibloc Group AG Schuldschein Refinancement De La Dette
BRIEF published on 05/13/2024 at 07:05, 2 years ago Newron Pharmaceuticals Announces Positive Results for Evenamide in Schizophrenia Study Clinical Study Schizophrenia Newron Pharmaceuticals Evenamide Mental Health Treatment
BRIEF published on 05/13/2024 at 07:05, 2 years ago Newron Pharmaceuticals annonce des résultats positifs pour l'Evenamide dans une étude sur la schizophrénie Schizophrénie Étude Clinique Produits Pharmaceutiques Newron Evenamide Traitement De Santé Mentale
BRIEF published on 05/13/2024 at 07:05, 2 years ago Air France-KLM Finalise le Remboursement d'Obligations OCEANE 2026 Remboursement Anticipé Marché Des Capitaux Finance D'entreprise Air France-KLM Obligations OCEANE
Published on 05/23/2026 at 19:45, 4 hours 12 minutes ago Golden Minerals Announces Closing of Equity Financing
Published on 05/23/2026 at 03:15, 20 hours 42 minutes ago UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 20 hours 57 minutes ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 21 hours 32 minutes ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 21 hours 32 minutes ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/23/2026 at 16:30, 7 hours 27 minutes ago HiFS 2026: Upgrading Four Major Digital Finance Solutions to Accelerate Financial Institutions Toward Agentic Banking
Published on 05/23/2026 at 15:57, 8 hours ago EQS-Adhoc: Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Published on 05/22/2026 at 22:05, 1 day 1 hour ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 1 day 1 hour ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 1 day 4 hours ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 19:35, 1 day 4 hours ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 1 day 5 hours ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 1 day 5 hours ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 1 day 11 hours ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 1 day 11 hours ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
